Search Results - "Folkeringa, N"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations

    Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations by COPPENS, M., FOLKERINGA, N., TEUNE, M. J., HAMULYÁK, K., VAN DER MEER, J., PRINS, M. H., BÜLLER, H. R., MIDDELDORP, S.

    Published in Journal of thrombosis and haemostasis (01-07-2007)
    “…Background: The factor V Leiden (FVL) and prothrombin 20210A (PTm) mutations are associated with single late pregnancy loss and recurrent early pregnancy loss…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Fetal loss in women with hereditary thrombophilic defects and concomitance of other thrombophilic defects: a retrospective family study

    Fetal loss in women with hereditary thrombophilic defects and concomitance of other thrombophilic defects: a retrospective family study by Korteweg, FJ, Folkeringa, N, Brouwer, J-LP, Erwich, JJHM, Holm, JP, van der Meer, J, Veeger, NJGM

    “…Please cite this paper as: Korteweg F, Folkeringa N, Brouwer J, Erwich J, Holm J, van der Meer J, Veeger N. Fetal loss in women with hereditary thrombophilic…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Fetal Loss in Women With Hereditary Thrombophilic Defects and Concomitance of Other Thrombophilic Defects: A Retrospective Family Study

    Fetal Loss in Women With Hereditary Thrombophilic Defects and Concomitance of Other Thrombophilic Defects: A Retrospective Family Study by Korteweg, F.J, Folkeringa, N, Brouwer, J.L, Erwich, J.J, Holm, J.P, van der Meer, J, Veeger, N.J

    Published in Obstetric anesthesia digest (01-06-2013)
    “…(BJOG. 2012;119(4):422–30)…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    31 Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss; a retrospective study

    31 Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss; a retrospective study by Folkeringa, N, Korteweg, F.J, Veeger, N.J.G.M, Erwich, J.J.H.M, van der Meer, J

    Published in Thrombosis research (2007)
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Session 18: Miscarriage: Treatment and Prognostic Factors

    Session 18: Miscarriage: Treatment and Prognostic Factors by Kaandorp, S. P., Goddijn, M., Post van der, J. A. M., Hutten, B. A., Verhoeve, H. R., Hamulyak, K., Mol, B. W., Folkeringa, N., Nahuis, M., Papatsonis, D. N. M., Buller, H. R., Veen van der, F., Middeldorp, S., Chakravarty, B. N., Chakraborty, P., Sharma, S., Mondal, A., Kabir, S. N., Bhattacharya, S., Love, E. R., Smith, N. C., Koot, Y. E. M., Boomsma, C. B., Eijkemans, M. C. J., Lentjes, E. G., Macklon, N. S., Rittenberg, V., Sobaleva, S., Al-Hadi, A., Khalaf, Y., Braude, P., El-Toukhy, T.

    Published in Human reproduction (Oxford) (01-06-2010)
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutation: reply to a rebuttal

    Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutation: reply to a rebuttal by COPPENS, M., FOLKERINGA, N., TEUNE, M. J., HAMULYÁK, K., VAN DER MEER, J., PRINS, M. H., BÜLLER, H. R., MIDDELDORP, S.

    Published in Journal of thrombosis and haemostasis (01-09-2007)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: